Twin Tree Management, LP Gilead Sciences, Inc. Call Options Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $40.1 Million - $50.5 Million	-601,800 Reduced 61.09%	383,300 $32.1 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $23.3 Million - $26.9 Million	-369,400 Reduced 27.27%	985,100 $67.6 Million
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $97 Million - $118 Million	1,354,500 New	1,354,500 $99.2 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $1.14 Million - $1.43 Million	-19,700 Reduced 4.58%	410,200 $24.4 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $15.5 Million - $17.6 Million	239,000 Added 125.2%	429,900 $31.2 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $6.74 Million - $7.27 Million	99,600 Added 109.09%	190,900 $13.3 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $2.14 Million - $2.44 Million	-35,600 Reduced 28.05%	91,300 $5.9 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $4.27 Million - $4.86 Million	-75,300 Reduced 37.24%	126,900 $7.39 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $9.34 Million - $10.8 Million	129,100 Added 176.61%	202,200 $15.6 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $2.96 Million - $3.31 Million	-47,300 Reduced 39.29%	73,100 $4.75 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $4.43 Million - $5.77 Million	73,100 Added 154.55%	120,400 $7.53 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $9.25 Million - $10.2 Million	-129,700 Reduced 73.28%	47,300 $3.65 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $3.04 Million - $3.54 Million	46,800 Added 35.94%	177,000 $12.5 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $4.25 Million - $5.18 Million	58,300 Added 81.08%	130,200 $9.82 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $9.9 Million - $11.6 Million	-139,200 Reduced 65.94%	71,900 $5.15 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $15.2 Million - $18 Million	211,100	211,100 $17.1 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account